India’s Travel Sector Growth: Tata Sons Chairman Sees Strong and Bright Future Ahead India travel sector growth continues to gain momentum, driven by the country’s robust consumption patterns and economic resilience. Speaking at the Annual General Meeting (AGM) of Indian Hotels Company Limited (IHCL), Mr. N. Chandrasekaran, Chairman of Tata Sons, shared an optimistic vision for the future of India’s hospitality and travel industry. Rising Consumption Fueling the Hospitality Sector At the AGM of IHCL—India’s […]

Jane Street Market Manipulation: SEBI Chairman Stresses Need for Stronger Surveillance Systems Jane Street Market Manipulation has raised pertinent concerns within India’s capital markets. However, SEBI Chairman Mr. Tuhin Kanta Pandey has assured stakeholders that such instances are not widespread and reaffirmed the regulator’s commitment to bolstering surveillance mechanisms. “No Many Other Risks Like Jane Street,” Says SEBI Chief Addressing the media in Mumbai on Monday, Mr. Pandey emphasized that the Jane Street market manipulation […]

 Mercury Ban in Cosmetics: Health Risks, Government Action & Safer Alternatives Summary India is planning a complete ban on mercury in cosmetics, targeting fairness creams, anti-ageing serums, and imported skincare products that may pose severe health risks. This move follows a recommendation by a top drug regulation panel and aims to align India with global safety standards like the Minamata Convention. Mercury in Cosmetics: What’s the Harm? That “glow overnight” fairness cream or anti-wrinkle serum […]

CDSCO Tightens Surveillance on Spurious Drugs in India After WHO Warning Summary India’s top drug regulator, CDSCO, is launching a nationwide crackdown on spurious and substandard medicines. This follows WHO’s sharp observations on India’s drug safety framework. Key actions include tighter advertising norms, public reporting portals, and stronger market surveillance. 🧪 Why This Matters Spurious Drugs in India India’s pharmaceutical sector is globally renowned for producing high-quality, affordable generics and vaccines. But the presence of spurious […]

SEBI Penalty Rationalisation: Regulator Plans Softer Terminology to Avoid Broker Stigma In a move that could significantly reshape regulatory perceptions in Indian capital markets, the Securities and Exchange Board of India (SEBI) is set to rationalise its penalty framework. According to Kamlesh Varshney, Whole-Time Member of SEBI, many regulatory actions currently termed as “penalties” are, in reality, procedural or compliance-related levies—and mislabelling them creates an unintended stigma on brokers and market intermediaries. 🔍 Why SEBI […]